1. The roles of collagens and fibroblasts in cancer
   Neel I. Nissen et al, 2024, Biochemistry of Collagens, Laminins and Elastin CrossRef
2. COL6A1 expression as a potential prognostic biomarker for risk stratification of T1 high grade bladder cancer: Unveiling the aggressive nature of a distinct non-muscle invasive subtype
   Kyeong Kim et al, 2024, Investigative and Clinical Urology CrossRef
3. Sulforaphane and bladder cancer: a potential novel antitumor compound
   Mingshun Zuo et al, 2023, Frontiers in Pharmacology CrossRef
4. In situ delivery of nanoparticles formulated with micron-sized crystals protects from murine melanoma
   Mona O Mohsen et al, 2022, Journal for ImmunoTherapy of Cancer CrossRef
5. Collagen code in tumor microenvironment: Functions, molecular mechanisms, and therapeutic implications
   Qian Zhang et al, 2023, Biomedicine & Pharmacotherapy CrossRef
6. Small Cajal Body-Specific RNA12 Promotes Carcinogenesis through Modulating Extracellular Matrix Signaling in Bladder Cancer
   Qinchen Lu et al, 2024, Cancers CrossRef
7. Integrative transcriptional characterization of cell cycle checkpoint genes promotes clinical management and precision medicine in bladder carcinoma
   Wei-Wei Shi et al, 2022, Frontiers in Oncology CrossRef
8. A novel interplay between PRC2 and miR‐3189 regulates epithelial–mesenchymal transition (EMT) via modulating COL6A2 in glioblastoma
   Vikas Sharma et al, 2024, Journal of Cellular Physiology CrossRef
9. A pan-cancer analysis of collagen VI family on prognosis, tumor microenvironment, and its potential therapeutic effect
   Xiang Li et al, 2022, BMC Bioinformatics CrossRef
10. Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms
    Hans Carl Hasselbalch et al, 2023, Cancers CrossRef
11. An Integrated Bioinformatics Analysis towards the Identification of Diagnostic, Prognostic, and Predictive Key Biomarkers for Urinary Bladder Cancer
    Michail Sarafidis et al, 2022, Cancers CrossRef
12. Leucine zipper protein 2 serves as a prognostic biomarker for prostate cancer correlating with immune infiltration and epigenetic regulation
    Dechao Feng et al, 2022, Heliyon CrossRef
13. Identification of molecular subtypes and diagnostic model in clear cell renal cell carcinoma based on collagen-related genes may predict the response of immunotherapy
    Yulong Hong et al, 2024, Frontiers in Pharmacology CrossRef
14. Global changes in chromatin accessibility and transcription in growth hormone-secreting pituitary adenoma
    Meng Wang et al, 2022, Endocrine CrossRef
15. Collagen Biomarkers Quantify Fibroblast Activity In Vitro and Predict Survival in Patients with Pancreatic Ductal Adenocarcinoma
    Neel I. Nissen et al, 2022, Cancers CrossRef
16. Discovering biomarkers for hormone-dependent tumors: in silico study on signaling pathways implicated in cell cycle and cytoskeleton regulation
    Klaudia Waszczykowska et al, 2022, Molecular Genetics and Genomics CrossRef
17. The pro-invasive factor COL6A2 serves as a novel prognostic marker of glioma
    Jinchao Zhu et al, 2022, Frontiers in Oncology CrossRef
18. Towards Understanding the Key Signature Pathways Associated from Differentially Expressed Gene Analysis in an Indian Prostate Cancer Cohort
    Nidhi Shukla et al, 2023, Diseases CrossRef
19. Role of COL6A2 in malignant progression and temozolomide resistance of glioma
    Xia Hong et al, 2023, Cellular Signalling CrossRef
20. A novel cancer-associated fibroblasts risk score model predict survival and immunotherapy in lung adenocarcinoma
    Fanhua Kong et al, 2024, Molecular Genetics and Genomics CrossRef
21. Collagen VI sustains cell stemness and chemotherapy resistance in glioblastoma
    Matilde Cescon et al, 2023, Cellular and Molecular Life Sciences CrossRef
22. Fibrotic activity quantified in serum by measurements of type III collagen pro-peptides can be used for prognosis across different solid tumor types
    Nicholas Willumsen et al, 2022, Cellular and Molecular Life Sciences CrossRef
23. Spectroscopic diagnosis and metabolite characterization of cisplatin resistance regulated by FDFT1 in bladder cancer tissue
    M. Kanmalar et al, 2024, Applied Radiation and Isotopes CrossRef